Client News
Filter by:
- Feb 1 2024 Panbela Announces Closing of Approximately $9.0 Million Public Offering
- Jan 30 2024 Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
- Jan 25 2024 Valero Energy Reports 2023 Fourth Quarter and Full Year Results
- Jan 18 2024 Valero Energy Corporation Increases Regular Cash Dividend
- Jan 16 2024 Paratek Pharmaceuticals Announces Promotion of Jonathan Light to General Counsel, Corporate Secretary and Chief Compliance Officer and Christopher Bostrom to Chief Financial Officer
- Dec 27 2023 ASHFORD SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES
- Dec 26 2023 ASHFORD RECEIVES LETTER OF NON-COMPLIANCE FROM NYSE AMERICAN
- Dec 21 2023 Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
- Dec 13 2023 Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List
- Dec 7 2023 Valero Energy Corporation to Announce 2023 Fourth Quarter and Full Year Earnings Results on January 25, 2024